The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies ...
Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...
In a Policy Forum, Chad Nelson and colleagues highlight the efforts of the U.S. Food and Drug Administration (FDA) in advancing alternative methods to reduce animal testing for regulatory use. Animal ...
Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...
FDA and NIH recently announced initiatives outlining specific actions each agency will take to encourage greater adoption of new and emerging technologies to reduce the need for — and potentially ...
A federal health agency is spending $4.3 million to keep SC’s famous Monkey Island on life support while debate rages over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results